A coalition of patient and provider groups, including the ACR, is raising awareness about the effect of pharmacy benefit managers (PBMs) on patient care and the cost of prescription drugs. The Alliance for Transparent and Affordable Prescriptions, or ATAP, argues that too few restrictions have been placed on PBM transparency, and requirements for PBMs to… [Read More]
Kathy Holliman, MEd, has been a medical writer and editor since 1997. She has worked on several publications focused on infectious diseases, cardiology, endocrinology, oncology/hematology, orthopedics, psychiatry, and pediatrics. Since becoming a freelance writer and editor in 2006, she has contributed to several healthcare publications in the fields of rheumatology, food quality and safety, internal medicine, and other medical association publications and medical education courses. Kathy has attended well over 100 medical meetings in the U.S. and Europe, and she continues to work as a writer and editor for onsite publications at several of those meetings.
Articles by Kathy Holliman
ACR/EULAR Response Criteria Approved for Adult, Juvenile Myositis
The ACR and EULAR have approved and released response criteria for adult and juvenile myositis, the result of a collaborative initiative that involved the International Myositis Assessment and Clinical Studies Group (IMACS) and the Paediatric Rheumatology International Trials Organisation (PRINTO). The decade-long collaboration was consensus driven, examined multiple clinical data sets and natural history studies,… [Read More]
ACR, EULAR Approve New Classification Criteria for Primary Sjögren’s Syndrome
Classification criteria for primary Sjögren’s syndrome (SS) have been approved by the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR), validating an international set of classification criteria for SS using standards set by both organizations. Those criteria can now be found in the 2016 ACR/EULAR Classification Criteria for Primary Sjögren’s Syndrome: A… [Read More]
Pain Linked to Inflammatory Lesions in Knee Osteoarthritis
Inflammation in the knee was found to be associated with development of pain sensitization in recent research with a cohort from the Multicenter Osteoarthritis Study (MOST). This research finding may indicate that targeting of inflammation could help reduce pain severity in knee osteoarthritis (OA). Tuhina Neogi, MD, PhD, says that her and her colleagues’ research,… [Read More]
Sexual Dimorphism Found in Immunologic Profiles of Patients with Ankylosing Spondylosis
A study that found distinct sexual dimorphism in the immunologic profiles of patients with ankylosing spondylosis (AS) suggests that sex is an important variable to address in future research and may eventually lead to more effective sex-specific therapy for patients with the disease. The research, published in the March 2016 issue of Arthritis & Rheumatology,… [Read More]
The ACR Continues Fight to Block Medicare Part B Demo Project: Rule Expected in Fall 2016
The ACR will seek Congressional action if the Medicare Part B demonstration project proposed by the Centers for Medicare & Medicaid Services (CMS) is not significantly altered by the agency. Today, Medicare Part B generally pays physicians and hospital outpatient departments the average sales price of a drug, plus a 6% add-on, minus reductions required… [Read More]
Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis
Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated…. [Read More]
New Bisphosphonate Therapy Recommendations for Postmenopausal Osteoporosis
A task force of the American Society for Bone and Mineral Research (ASBMR) has released new recommendations delineating the potential benefits and risks of prolonged therapy with oral and IV bisphosphonate therapy and providing guidance on duration of bisphosphonate therapy for postmenopausal osteoporosis.1 The task force makes clear that data and clinical experience on which… [Read More]
2016 Deadline Imposed by Meaningful Use Program Requires Immediate Attention: Sign Up for 2 Registries by Feb. 29 or Expect Financial Penalty
Meaningful Use may be changing but it is not going away—yet. Rheumatologists must sign up with two of three registries by Feb. 29 or pay significant financial penalties for not complying with this specific part of the Meaningful Use requirements. The three choices for registries include the Immunization Registry, the Syndromic Surveillance Registry and a… [Read More]
Rheumatologists on the Move, November 2015
Nancy Baker, ScD, Completes Sabbatical Year at CDC Nancy Baker, ScD, MPH, OTR/L, associate professor in the Department of Occupational Therapy at the University of Pittsburgh, recently completed a yearlong sabbatical as a researcher at the Centers for Disease Control & Prevention (CDC), Division of Population Health. Her mentor at the CDC, Kristina Theis, MPH,… [Read More]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »